Measuring Amyloid-Beta, total tau (T-tau), and hyperphosphorylated tau (p-tau) in CSF proteins has proved accurate in diagnosing AD (Ritchie et al., 2017; Zetterberg, 2019). This evidence concerns the gene MAPT and Alzheimer disease.